دورة تكنولوجيا السكري 2025
✨تعرف على:
🔺أحدث أنظمة مراقبة الجلوكوز المستمرة ومضخات الإنسولين.
🔺تعلم كيفية تحليل بيانات AGP بثقة وتحليل تقارير مضخات الإنسولين.
🔺تعلم أنماط هبوط وارتفاع السكر والمنحنيات ودلالاتها.
🔺ستتمكن من تطبيق أهداف الوقت في النطاق (TIR).
🔺أمثلة لحالات حقيقية وكيفية التعامل معها.
🔺فرصة للتفاعل في جلسة أسئلة وأجوبة مع خبراء تكنولوجيا السكري.
📅التاريخ: 2025/07/29
📍يوم الأربعاء
⏰ 8:00 - 10:30 مساءً
📲 أونلاين وستكون مسجلة ومتاحة بالموقع
✅يوجد شهادة حضور
للتسجيل عبر الرابط:
خصم 20% عند إدخال كود AB
https://vistamed.osarh.pro/lesson/4/tech
Ad
✨تعرف على:
🔺أحدث أنظمة مراقبة الجلوكوز المستمرة ومضخات الإنسولين.
🔺تعلم كيفية تحليل بيانات AGP بثقة وتحليل تقارير مضخات الإنسولين.
🔺تعلم أنماط هبوط وارتفاع السكر والمنحنيات ودلالاتها.
🔺ستتمكن من تطبيق أهداف الوقت في النطاق (TIR).
🔺أمثلة لحالات حقيقية وكيفية التعامل معها.
🔺فرصة للتفاعل في جلسة أسئلة وأجوبة مع خبراء تكنولوجيا السكري.
📅التاريخ: 2025/07/29
📍يوم الأربعاء
⏰ 8:00 - 10:30 مساءً
📲 أونلاين وستكون مسجلة ومتاحة بالموقع
✅يوجد شهادة حضور
للتسجيل عبر الرابط:
خصم 20% عند إدخال كود AB
https://vistamed.osarh.pro/lesson/4/tech
Ad
❤5
How prokinetics work in the GI tract
📸: https://onlinelibrary.wiley.com/doi/10.1111/nmo.14774
H/T @drkeithsiau on 𝕏
📸: https://onlinelibrary.wiley.com/doi/10.1111/nmo.14774
H/T @drkeithsiau on 𝕏
Wiley Online Library
Prokinetics‐safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology…
Background
Prokinetics are a class of pharmacological drugs designed to improve gastrointestinal (GI) motility, either regionally or across the whole gut. Each drug has its merits and drawbacks, and...
Prokinetics are a class of pharmacological drugs designed to improve gastrointestinal (GI) motility, either regionally or across the whole gut. Each drug has its merits and drawbacks, and...
A previously healthy 42-year-old man presented with a 20-day history of an expanding, asymptomatic rash on his trunk. The initial lesion had been a red spot on the patient’s left side. 10 days after that spot had first appeared, smaller lesions had developed elsewhere. The patient reported no viral prodrome. The skin examination — including the initial lesion that had appeared — is shown. What is the diagnosis?
❤1
Family Medicine notes
A previously healthy 42-year-old man presented with a 20-day history of an expanding, asymptomatic rash on his trunk. The initial lesion had been a red spot on the patient’s left side. 10 days after that spot had first appeared, smaller lesions had developed…
ANSWER: ✅ Pityriasis rosea (P.rosea)
On the basis of the finding of a “herald” patch in the patient’s midaxillary line on the left side, a diagnosis of pityriasis rosea was made. Pityriasis rosea is a self-limiting disorder that typically affects children, adolescents, and young adults. The cause of pityriasis rosea remains unclear. It may be related to viral reactivation of human herpes virus 6 or 7.
© NEJM image challenge
On the basis of the finding of a “herald” patch in the patient’s midaxillary line on the left side, a diagnosis of pityriasis rosea was made. Pityriasis rosea is a self-limiting disorder that typically affects children, adolescents, and young adults. The cause of pityriasis rosea remains unclear. It may be related to viral reactivation of human herpes virus 6 or 7.
© NEJM image challenge
The New England Journal of Medicine
September 4, 2025 | NEJM
Image Challenge from the New England Journal of Medicine — September 4, 2025
❤10
2026_acc_aha_aacvpr_abc_acpm_ada_ags_apha_aspc_nla_pcna_guideline.pdf
21.7 MB
🆕 2026 ACC/AHA Guideline on the Management of Dyslipidemia (DLP)
❤2👍2
Causes and management of Hypertriglyceridemia (↑ TG)
📌 Still you need to focus on ASCVD reduction as a priority especially for non-severe hyperTG
🆕 2026 Dyslipidemia (DLP) AHA/ACC guideline
📌 Still you need to focus on ASCVD reduction as a priority especially for non-severe hyperTG
🆕 2026 Dyslipidemia (DLP) AHA/ACC guideline
❤2
❤️ PREVENT score for ASCVD assessment
https://professional.heart.org/en/guidelines-and-statements/prevent-calculator
🆕 2026 Dyslipidemia (DLP) AHA/ACC guideline
https://professional.heart.org/en/guidelines-and-statements/prevent-calculator
🆕 2026 Dyslipidemia (DLP) AHA/ACC guideline
professional.heart.org
The American Heart Association PREVENT™ Online Calculator
Welcome to the American Heart Association Predicting Risk of cardiovascular disease EVENTs.
❤2👍1
saudi_consensus_statements_on_the_management_of.189.pdf
1.9 MB
🆕🇸🇦 Saudi consensus statements on the management of irritable bowel syndrome (IBS)
👍3